How Engaging Patients in Trial Design Maximizes Orphan Drug Success

 

In the following article by the Journal for Clinical Studies, Worldwide’s Dr. Michael Murphy, Chief Medical and Scientific Officer, and Barbara Zupancic, Senior Director of Patient Recruitment and Retention, discuss the elements of a patient-centric trial design, in addition to high-quality patient engagement and its impact on orphan drug success.

Questions regarding your upcoming clinical trial?